Latest Articles

This article explores how advances in automation, 3D cell models and AI are transforming high-throughput screening, driving faster and more predictive drug discovery.

IgE, best known for mediating allergic reactions, may also shape cancer outcomes. Learn how this immune molecule could serve as both a biomarker and a basis for next-generation therapies.

Addressing critical proteomics challenges in the lab, including robust sample preparation, managing batch effects in experimental design, and ensuring data quality integrity for reliable results.

DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker 5hmC, to track active gene regulation through blood samples.

In celebration and support of UK Black History Month and this year’s theme, “Standing Firm in Power and Pride,” this article explores diversity in science and how it shapes who leads research and who benefits from it.

Experts at ASHG 2025 will tackle clinical and genetic research challenges on sex, gender and sexuality, exploring ethics, advocacy and inclusion.

Technology Networks spoke with Dr. Alice Fleerackers about how reputation-driven shortcuts in science journalism shape public trust, sideline diverse voices and why fostering critical research literacy could transform how science is reported.

This article explores how immune biomarkers can predict disease risk, guide treatment choices and overcome challenges to advance personalized medicine.

In this interview with Professors Itai Yanai and Martin Lercher, explore how night science brings creativity, ideation and collaboration back into the heart of modern science.

Molecular glues hold strong therapeutic promise for approaches such as targeted protein degradation (TPD) and beyond, yet systematic identification remains challenging. But GlueSEEKER could help to overcome this problem.